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Overexpression of transforming growth factor–1
correlates with increased synthesis of nitric oxide
synthase in varicose veins
Theresa Jacob, PhD, Anil Hingorani, MD, and Enrico Ascher, MD, Brooklyn, NY
Introduction: Transforming growth factor-1 (TGF-1) is known to maintain a balance between apoptosis and cellular
dysfunction and therefore may have a pivotal role in vessel remodeling during pathogenesis of vascular disorders. We
previously demonstrated that inducible nitric oxide synthase (iNOS) mediates signal transduction in vascular wall during
the development of varicose veins. Currently, we investigated the expression and correlation of TGF-1, iNOS,
monocyte/macrophage infiltration, and loss of vascular smooth muscle cells (VSMCs), in a series of normal and varicose
vein specimens.
Methods: Twenty varicose vein specimens were retrieved from 20 patients undergoing lower-extremity varicose vein
excision, and 27 normal greater saphenous vein segments (controls) were obtained from 27 patients undergoing
infrainguinal arterial bypass surgery. Principal risk factors (diabetes mellitus, hypertension, tobacco abuse) were also
compared. Varicose vein segments were separated into tortuous and nontortuous regions based on their macroscopic and
microscopic morphology. VSMC actin, CD68 monocytes/macrophages, iNOS, and TGF-1, were examined by
immunohistochemistry, immunoblotting, and real-time reverse transcriptase polymerase chain reaction.
Results:According to the CEAP classification for chronic lower extremity venous disease, most of the patients were in class
2 for clinical signs of the disease (n  11). Mean ages were 53.6  4.7 years for the varicose vein group and 56.5  4.4
years for the controls. The gender distribution was same in both groups. Immunoreactivity to TGF-1 and iNOS was
significantly different in the tortuous regions of the varicose veins compared with nontortuous regions (P < .01). Not
only was a significantly higher expression of iNOS noted in the varicose vein group (P < .001), but a differential
expression of iNOS was also observed in the tortuous and nontortuous portions of the varicose veins. Significant
overexpression of TGF-1 (P< .01) that correlated with overproduction of iNOS and with increased presence of CD68
monocytes/macrophages was observed in the varicose vein walls compared with normal veins.
Conclusions: This is the first evidence of TGF-1, as well as iNOS, being differentially upregulated in nontortuous and
tortuous segments of varicose veins. The increased expression of TGF-1 and presence of macrophages, correlating with
overproduction of iNOS, may be associated with varicosity development and deserves further study. (J Vasc Surg 2005;
41:523-30.)
Clinical Relevance: The pathogenesis of varicose veins, the most common manifestation of chronic venous disease, is
debatable. Elucidation of mechanisms involved in the disease process is the first step to improved therapeutic modula-
tions. Towards this goal, the relationship between NO production and TGF-1 in the molecular pathophysiology of
chronic venous disease was investigated. The data identify for the first time, an important role for TGF-b1—iNOS—
monocyte/macrophage signaling in the etiology of varicosities. Furthermore, we determine if there are any significant
differences within the varicose vein group itself based on regional differences, by classifying the varicose tissues into
tortuous and non-tortuous segments.Primary varicose veins, the most common manifesta-
tion of chronic venous insufficiency, affect up to 30% of
people in Western countries.1 The abnormal dilatation and
tortuosity, hallmarks of varicose veins, provide evidence for
venous wall remodeling.2 Cell cycle dysfunction and dereg-
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doi:10.1016/j.jvs.2004.12.044ulated turnover of the cells within the vein wall has been
suggested to contribute to this remodeling in varicose
veins.3,4 The degree of cellularity in the vein wall is deter-
mined by the balance between the migration and prolifer-
ation of cells relative to their rate of egress and apoptosis.
We observed significant differences in the expression and
subcellular localization of the cell cycle regulatory protein,
cyclin D1, in varix tissues compared with normal veins5 and
demonstrated that deregulated apoptosis plays a role in the
pathogenesis of varicosities.6
Transforming growth factor-1 (TGF-1), an isoform
of the fibrogenic cytokine TGF-, is a multifunctional
25-kDa polypeptide that regulates diverse cellular func-
tions such as proliferation, migration, differentiation, and
extracellular matrix production. TGF-1 can act as a potent
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cular cells.7 It has been shown to stimulate -smooth
muscle actin expression in fibroblasts both in vivo and in
vitro8,9 and also enhance the formation of the structural
elements important for contractile force generation.10 In
vascular disease, TGF-1 is known to have a dualistic role
and act as a bifunctional regulator of vascular smooth
muscle cell (VSMC) proliferation, migration, and pheno-
type.11 Hence, we hypothesized that this pleiotropic mol-
ecule can regulate the remodeling observed in varicosity
development.
On the other hand, hypotheses that varicosities are
caused by hydrostatic phenomena promoted by valvular
incompetence lead to the thought that a significant factor
in the pathogenesis of lower extremity varicose veins is
vascular tone. Nitric oxide (NO), a potent intercellular
molecular messenger, not only regulates vascular tone but
also has diverse pathophysiologic functions such as inhibi-
tion of platelet adhesion/aggregation, mediation of the
inflammatory cascade, neurotransmission, and cytotoxicity,
among others.12
Additionally, NO is also a pleiotropic agent that has
been linked to the signaling and execution of apoptotic
cascades.13 It either acts within the endothelium in which it
is produced constitutively by endothelial NO synthase
(eNOS), or it penetrates the endothelial layer affecting
SMCs, which may also generate NO by inducible NO
synthase (iNOS).14 Whereas eNOS is calcium-dependent
and produces small amounts of NO on stimulation, iNOS is
a cytokine-inducible, calcium-independent, high-output
enzyme that can be produced by almost any nucleated cell
given the appropriate inflammatory stimulus.15
Several reports have referred to the modulation of cell
proliferation and apoptosis by TGF and iNOS. Increased
output of NO is also known to cause overexpression of
TGF-1. However, this link between NO production and
TGF-1 has not been investigated in the pathogenesis of
varicose veins.
The current investigation examines the expression of
TGF-1, iNOS, and eNOS in a series of varicose vein and
normal vein specimens. The study determines if there are
differences in the expression of these molecules in tortuous
and nontortuous regions of varicose veins.
MATERIALS AND METHODS
This investigation was approved by the institutional
review board of Maimonides Medical Center, and the
patients gave written consent.
Patients. Twenty varicose vein specimens were atrau-
matically harvested from 20 patients undergoing lower-
extremity varicose vein excision. The operative indications
were pain, edema and venous stasis disease, or cosmetic
purposes. All patients had symptoms 6 months. Accord-
ing to the CEAP classification of American Venous Fo-
rum16 for chronic lower-extremity venous disease, 11 pa-
tients were in class 2 for clinical signs, 4 in class 3, 4 in class
4, and 1 in class 5. All patients were characterized as having
primary varicosities except one patient who had secondaryvaricosities. Only the greater saphenous vein and its tribu-
taries were studied. The greater saphenous vein specimens
were collected from the thigh region and the tributaries
from the calf region. A few tributaries were included to see
if the results were similar.
The control group was 27 normal greater saphenous
vein specimens obtained from 27 patients undergoing in-
frainguinal arterial bypass surgery who had no history of
venous disease or evidence of reflux. None of these patients,
histologically or by duplex examination, demonstrated ve-
nous thrombosis, and their vein segments were found to be
free of acute or chronic inflammation by hematoxylin and
eosin staining. All greater saphenous vein segments were
from the thigh region, whereas the three greater saphenous
vein normal tributaries included in the control group were
from the distal calf region.
A preoperative lower-extremity venous duplex ultra-
sound assessment was performed on all patients. The super-
ficial and the deep venous systems were studied by a stan-
dard method of examination as previously described.6
Briefly, venous duplex sonography was performed on each
patient beginning at the common femoral vein and con-
tinuing distally to the tibial and peroneal veins. Transverse
and longitudinal views of the veins were obtained to deter-
mine venous flow with respiration and augmentation ma-
neuvers and to document echogenic signals within the vein
lumen to identify thrombus.
Tissue specimens. Upon atraumatic harvest, vein
specimens were divided into two portions, of which one
was immediately snap-frozen in liquid nitrogen. All speci-
mens were transported to the lab. The varicose veins were
classified as nontortuous or tortuous depending on their
tortuosity, as evident upon macroscopic and microscopic
examination by a pathologist and an investigator, after
which they were processed.
The time taken to process all specimens was kept uni-
form, with no differences in the processing of varicose or
normal vein samples. The frozen specimens were homoge-
nized in denaturation/lysis buffer for RNA extraction and
protein analyses. The remaining portion was fixed in 10%
neutral buffered formalin solution containing3.7% form-
aldehyde (W:V) for 6 to 12 hours and embedded in paraf-
fin. Five segments of each vein specimen were embedded in
each paraffin block. Transversal tissue sections of 5-m
thickness were mounted on poly-L-lysine coated slides.
Each slide had five sections of one vein specimen.
Histology. Routine hematoxylin and eosin staining
was performed for histologic evaluation of the specimens.
Gomori’s one-step trichrome staining was used to identify
changes in collagenous connective fibers and to differenti-
ate between collagen and smooth muscle fibers in both
normal and varicose vein specimens. Verhoeff’s elastic tis-
sue stain (with van Gieson’s stain to counterstain) was
performed to assess the pathologic changes in the elastin
network in all the veins included in the study.
Detection of TGF-1 transcripts. For RNA extrac-
tion, snap-frozen vein tissue homogenates underwent pro-
teinase K digestion before total RNA was extracted using
nthase
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according to the manufacturer’s standard protocol. mRNA
expression of TGF-1 was determined by real-time reverse
transcriptase polymerase chain reaction (RT-PCR) by using
the GeneAmp 5700 SDS instrument (Applied Bio-Systems,
Foster City, Calif) using reagents from QuantiTect Probe
RT-PCR kit (Qiagen, Valencia, Calif), according to the
manufacturer’s instructions.
Total RNA (10 ng) from the vein tissues was used to
reverse transcribe and PCR-amplify mRNA transcripts with
TGF-1 gene-specific primers: forward primer, 5’-CCT
GGCGATACCTCAGCAA-3’; reverse primer, 5’-CCGGT
GACATCAAAAGATAACCA-3’; and a fluorescent re-
porter probe, 5’-6FAM-CTGGCACCCAGCGACTCGC-
BHQ1-3’. The amount of fluorescence detected is
proportional to the amount of the PCR product formed
and is calculated in real-time with GeneAmp 5700 SDS
software.
The RT-PCR conditions were reverse transcription for
30 minutes at 50oC; initial denaturation at 95oC for 15
minutes, and 40 amplification cycles with denaturation at
94oC for 15 seconds, annealing, and extension at 60oC for
1 minute. Samples were analyzed in duplicate PCR reac-
tions and data from two separate experiments were aver-
aged for analysis. The sequence for glyceraldehyde phos-
phate dehydrogenase (GAPDH), a housekeeping gene, was
used as an internal control.
Detection of TGF-1 and NOS expression.
TGF-1, eNOS, and iNOS were detected in the vein walls
by Western blotting, localized in vivo by immunohisto-
chemistry as previously described,6 and double staining was
performed for co-localizing them with the various cell
types.
Western blot analysis. Frozen venous tissue homog-
enates in a buffer containing 50mM Tris-HCl (pH 7.5) and
Table I. Antibodies used for immunohistochemistry in va
Antibody Clone/origin Manufacturer
Alpha actin IA4 DAKO
CD68 KP-1 DAKO
TGF-1 Rabbit polyclonal SantaCruz
eNOS Rabbit polyclonal Transduction Labs
iNOS Rabbit polyclonal Endogen
TGF-1, Transforming growth factor-1; eNOS, endothelial nitric oxide sy
Table II. Patient demographics and clinical risk factors
Normal vein
(n 	 27)
Varicose vein
(n 	 20) P
Age 
 SEM (years) 56.5 
 4.4 53.6 
 4.7 NS
Male:female (24:23) 14:13 10:10 .9
DM (n 	 8) 6 2 .27
HTN (n 	 8) 5 3 .75
Tobacco use (n 	 5) 4 1 .28
SEM, Standard error of mean; DM, diabetes mellitus; HTN, hypertension.
P values compare varicose vein to normal veins.a cocktail of protease inhibitors (Sigma Chemical, St.Louis, Mo) were used for immunoblotting. Equalized pro-
tein samples were electrophoresed using the Laemmli
buffer system. Electrotransfer of the proteins was made to a
polyvinyl diflouride membrane, and after blocking of non-
specific immunoglobulin (Ig) G binding, the membrane
was incubated in primary antibodies overnight at 4°C.
Bands were detected using horseradish-linked immunoas-
say by enhanced chemiluminescence system. Densitometric
analysis of the immunoblots was performed using NIH
ImageJ (Image-Pro Express v. 4.0) software. Blots were
stripped and re-probed by standard protocols. Data are
expressed as arbitrary units representative of three separate
blotting experiments.
Immunohistochemistry. Localization of the expres-
sion of TGF-1, eNOS, and iNOS was by standard immu-
nohistochemical techniques as previously described,6 with
primary antibodies and dilutions as shown in Table I. For
double staining (10 varicose vein, 4 control specimens),
anti--SM actin or CD68 was detected in the usual
method with DAB substrate. TGF-1, eNOS, and iNOS
were then localized by substituting peroxidase labeling
with alkaline phosphatase-labeled avidin and detected us-
ing Fast Red.
Observation. The expression of proteins was evalu-
ated according to staining intensity and immunocytochem-
ical distribution-cytoplasmic and nuclear staining, based on
the results of two independent blinded investigators. After
the entire section was scanned at 20 magnification and
compared with the negative control, positive cellular ex-
pression was noted and the total number of immunoreac-
tive cells determined at 400 magnification. Ten random
fields for each section and 5 sections for each specimen were
evaluated.
Statistical analysis. The patient demographics data
were analyzed by t test and 2. The Fisher exact test was
used to compare the results obtained in the different
groups. One-way analysis of variance (ANOVA) with post-
hoc Bonferroni multiple comparison test was used to com-
pare the TGF-1, eNOS, and iNOS expression in control,
nontortuous varicose vein, and tortuous varicose vein
groups. P  .05 was considered statistically significant.
Statistical analyses were performed using StatView software
(SAS Institute, Cary, NC). The Spearman nonparametric
correlation of NOS versus TGF was calculated using Statis-
tical Package for the Social Sciences (SPSS) software, ver-
e and normal veins
Titer Antigen Retrieval
1:50 pressure cooker, 0.25M Tris-base buffer, pH 9.0
1:6000 pressure cooker, 10mM Citrate buffer, pH 6.0
1:200 pressure cooker, 10mM Citrate buffer, pH 6.0
1:1000 pressure cooker, 0.25M Tris base buffer, pH 9.0
1:1000 pressure cooker, 10mM Citrate buffer, pH 6.0
; iNOS, inducible nitric oxide synthase.ricossion 8.0 (SPSS Inc.; Chicago, Ill).
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Patient demographics and clinical characteristics.
Demographics of patients in this study are shown in Table
II. Table III gives the detailed information about each
patients’ disease status and the clinical, etiologic, anatomic,
and physiologic classification. All patients from the varicose
vein group exhibited reflux in the greater saphenous vein.
In 7 patients, the deep venous system was also affected, 5
with reflux and 2 with reflux and evidence of concomitant
nonocclusive deep venous thrombosis. Two patients in the
varicose vein group had duplex evidence of greater saphe-
nous vein thrombosis. Although in all patients the greater
saphenous vein exhibited reflux, the lesser saphenous vein
was also affected in 40%. The deep venous segments, com-
mon femoral, superficial femoral, and popliteal vein exhib-
ited reflux in 20% of patients. Only two patients demon-
strated reflux in the iliac vein and one in the deep femoral
vein.
Histology. Consistent with our previous reports and
those of other investigators, varicose vein specimens exhib-
ited a more disorganized architecture compared with nor-
mal veins. Heterogeneity of the varicose vein wall was clear,
and tortuous as well as nontortuous segments could be
identified. The nontortuous segments bore considerable
similarity in appearance to the normal vein segments. Hy-
pertrophic regions and atrophic portions were distinct, but
hypertrophic regions predominated atrophic areas in this
study.
The medial layer was severely disorganized and exhib-
ited a haphazard array of VSMCs (actin immunostaining),
especially in tortuous varicose vein segments. The intimal
layer exhibited cushion-like thickening in several areas. In
the adventitia, the number of vasa vasorum was increased.
Gomori’s trichrome staining showed conspicuously de-
Table III. Clinical, etiologic, anatomic distribution, and p
Class 2 (n 	 11) Class 3 (n 	 4)
Male Male
C2 EP AS2-3 PR C3 EC AS2,4 PR
C2 EP AS2 PR C3 EP AS2-3; D11,13 PR
C2 EP AS2 PO
C2 EP AS2-3; D11,13 PR Female
C2 EP AS2-3 PR C3 EP AS2-3; D11,13,14 PR
C3 EP AS2-3; D7,9,14 PR
Female
C2 EP AS2-3 PR
C2 EP AS1-4 PR
C2 EP AS2-3 PR
C2 EP AS2-3 PR
C2 EP AS2-3 PR
C2 EP AS2-3 PR
C (class): class 2, varicose vein; class 3, edema; class 4, hyperpigmentation, v
E (etiology): EP, primary; EC, congenital; ES, secondary.
A (anatomy): AS, superficial veins (AS1-5); S1, telangiectasias/reticular vein
saphenous vein; AD, deep veins (AD6-16); D7, common iliac; D9, external
popliteal; AP, perforatoring veins (AP17,18); P17, thigh, P18, calf.
P (pathophysiology): PR , reflux; PO, obstructive.creased collagen matrix in varicose veins compared withnormal veins. Verhoeff’s elastin staining demonstrated in-
creased degradation of elastin network. The wall layers of
the varicose vein tissues, in addition to disruption of elastic
lamellae, also revealed a significantly high degree of loss of
VSMCs, although the VSMCs appeared enlarged. Mono-
cytes/macrophages or cells immunopositive for antibody
to CD68 were observed rarely in normal vein wall but were
observed frequently in the varicose vein wall layers.
Transcription of TGF-1. RT-PCR revealed an in-
creased amount of TGF-1 gene transcripts in varicose vein
tissues. The differences between the two varicose vein
groups was significant, with the greater amount of mRNAs
being present in the tortuous segments of the varix tissues
(Table IV). The increased level of TGF-1 in varicose vein
samples correlated with immunostaining data. Only a very
small amount of expression of TGF-1 was detected in
control vein samples (P  .01).
Differential expression of TGF-1. Normal venous
tissues exhibited negligible immunopositivity to antibody
for TGF-1. TGF-1 expression was both focal and pan-
tropic in the mural layers of the varicose vessels. Cytoplas-
physiology (CEAP) data
Class 4 (n 	 4) Class 5 (n 	 1)
Male Male
C4 EP AS2-4; D9,11-14 PR C5 EP AS4; D14; P18 PR
C4 ES AS2-3; D11,13,14 PR, O
Female
C4 EP AS2-4; D11,13,14 PR
C4 EP AS2-3; D11,13 PR
eczema, or lipodermatosclerosis; class 5, healed ulceration.
great saphenous vein (GSV) above knee; S3, GSV below knee, S4, lesser
11, common femoral; D12, deep femoral; D13, superficial femoral; D14,
Table IV. Real-time reverse transcriptase polymerase
chain reaction: gene transcripts in nanograms
Normal vein
(n 	 10)
Varicose vein
nontortuous
(n 	 10)
Varicose vein
tortuous
(n 	 10) P
TGF-1 0.22 2.96 8.54
GAPDH 0.571 0.258 0.362
TGF-1/
GAPDH
0.38 
 0.5* 11.47 
 3.6* 23.6 
 5.8* .01
TGF-1, Transforming growth factor-1; GAPDH, glyceraldehyde phos-
phate dehydrogenase.
*Data are means 
 SEM and significant.atho
enous
s; S2,
iliac; Dmic and nuclear localization of TGF-1 was observed in the
drogenase.
expression in tortuous varicose vein tissue (original magnifica
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CD68 cells expressing TGF-1. Predominant expression
of TGF-1 was in the adventitial layer and in regions of
intimal fibrosis. However, the amount of protein for this
relatively unique cytokine was diminished in the nontortu-
ous segments compared with the tortuous segments of the
varicose vein (P  .05). This was also confirmed in the
Western blot analysis (Figs 1 and 2). Densitometric evalu-
ation of the immunoblots revealed TGF-1 protein bands
were of 2853 and 12280 units (arbitrary units, pixel den-
sity) in nontortuous and tortuous varicose vein segments
respectively. Within tortuous varicose vein segments, in
hypertrophic areas, there were 35.7% 
 4.8% cells positive
for TGF-1; whereas in the nontortuous varix tissues, only
17.7% 
 1.14% cells expressed this protein.
Expression of eNOS. Expression of this isoform of
NOS could be detected in the venous wall by immunologic
techniques in the current study and was similar to observa-
tions in our previous study. There was no significant differ-
emical analysis in vein wall (all at original magnification
edded tissues were processed for immunolocalization of
ase) (arrows) indicates immunopositivity. Photomicro-
). Nontortuous varicose vein (vv). B, CD68 cells in
(TGF-1) in control vein (nv) tissue. D, TGF-1 in
synthase (iNOS) expression in control vein. F, iNOS
tion 200).Fig 2. Western blot analysis for expression of transforming
growth factor-1 (TGF-1) and inducible (iNOS) and endothelial
(eNOS) nitric oxide synthases. Comparison of the normal vein
(NV), tortuous varicose vein (VV-t), and nontortuous varicose
vein (VV-nt) segments. GAPDH, glyceraldehyde phosphate dehy-Fig 1. Representative photomicrographs of immunohistoch
400 unless indicated otherwise). Formalin-fixed paraffin-emb
proteins as described under Methods. Brown staining (peroxid
graphs depict the staining pattern. A, Negative control (nc
tortuous varicose vein. C, Transforming growth factor-1
non-tortuous varicose vein tissue. E, Inducible nitric oxideence in expression of eNOS between the three vein groups.
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1975, 2297, and 2643 units in controls, nontortuous, and
tortuous varicose vein segments respectively (Figs 1 and 2).
Immunohistochemistry revealed its predominant localiza-
tion to the endothelium and the endothelial cells of the vasa
vasorum. Some smooth muscle cells also were positive for
eNOS.
Differential expression of iNOS. Normal venous tis-
sues exhibited negligible immunopositivity to the antibody
for iNOS. Immunohistochemical staining demonstrated
intense staining in several focal areas of the varicose vein
wall and confirmed our previous results. This staining was
absent from the negative controls. The varicose vein dem-
onstrated a large number of cells expressing iNOS, with
46.28% 
 3.5% positive cells in tortuous varicose vein
segments (P  .001). However, in the nontortuous seg-
ments, less than half that number of cells expressed iNOS
(P  .001) and it was localized to infiltrating elements.
Only varicose vein walls had CD68 cells expressing iNOS.
We did not note any protein band corresponding to 130
kD for iNOS in the tissue homogenate of normal venous
wall. In contrast, the protein profile of samples of varicose
vein specimens demonstrated significant amount of protein
(Figs 1, 2, and 3). Densitometric evaluation of the immu-
noblots revealed iNOS protein bands were of 6281 units in
nontortuous and 7897 units in tortuous varicose vein seg-
ments.
The Spearman nonparametric correlation of NOS ver-
Expression of iNOS and TGF-beta1 in vein segments
0
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Fig 3. Immunohistochemical analysis for expression of trans-
forming growth factor-1 (TGF-1) and inducible nitric oxide
synthases (iNOS). Comparison of the normal vein (NV), tortuous
varicose vein (VV-t) and non-tortuous varicose vein (VV-nt) seg-
ments. All values are expressed as mean 
 SEM. Values for
tortuous varicose vein and normal vein segments were significantly
different (P  .01).sus TGF was significant at the 0.01 level (2-tailed). Perhapsbecause of their small numbers, we did not observe any
differences in the outcomes of tributaries compared with
whole segments.
DISCUSSION
The present investigation demonstrates the expression
of TGF-1 and NO synthases in the vessel wall of normal
and varicose veins. Overexpression of TGF-1 that corre-
lated with the upregulation of iNOS was observed in vari-
cose vein specimens. Few studies have provided informa-
tion at the molecular level based on regional histologic
differences within the vein wall. Hence, to determine if
there were any significant differences within the varicose
vein group itself based on such regional differences, we
classified the varicose tissues to tortuous and nontortuous
segments. We demonstrated that the presence of TGF-1
and iNOS-positive cells was not only high in varix tissues
compared with the controls but also that these molecules
were differentially expressed in the tortuous and nontortu-
ous segments of the varicose veins. The expression of
TGF-1 and iNOS was also observed in the cells positive for
smooth muscle -actin and CD68.
Varicosis is a complex pathology characterized by ve-
nous hypertension, blood stagnation, and reflux leading to
progressive venous wall remodeling evidenced by abnormal
dilatation and tortuosity. There are several theories regard-
ing the pathogenesis of varicosities. The primary cause is
still unknown, although ample evidence implicates that the
defect is in the wall of the lower limb veins. 17 It has also
been suggested that increased expression of basic fibroblast
growth factor and TGF-1 by varicose vein cells may have a
pivotal role in the hypertrophy of the venous wall, although
the exact mechanism leading to venous wall dilatations
remains to be elucidated.18 Our previous data on deregu-
lated cell cycle and apoptosis and the hypertrophy observed
in several regions of varicose veins lend credence to this
observation.5,6
Resistance to apoptosis may have dual effects, increase
the volume of the resistant cell subsets, and lead to the slow
proliferation of these cells, thereby contributing to the focal
progression of mural layer hypertrophy. Bujan et al19 re-
ported an increase in apoptosis and collagen synthesis in
varicosities that contradicted our results and those of Ur-
banek et al,3 who also found a down-regulation of VSMC
apoptosis in varicose veins. However, their recent work
demonstrates greater expression of TGF-1 and its latent
polypeptide in varicose veins.20 Both molecules were de-
tected in the subendothelium and the media, particularly in
areas of marked injury. Our findings and those of several
others also suggest that the development of the varicose
condition involves a restructuring of the elastic component
of the vein wall, perhaps as a consequence of changes in the
transcription mechanisms of muscle layer cells.
That TGF-1 has been found to be crucial in promot-
ing connective tissue deposition underscores its role in the
molecular events that lead to the remodeling and the
acceleration of the final fibrosclerotic process characteristic
of the varicose vein wall. However, the data from this study
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crease and degradation of extracellular matrix in varicose
veins. Perhaps vein cells respond differently to TGF-1
stimulation. Other studies have demonstrated an increase
in metalloproteinases. It would be interesting to look at
total collagen in the veins, but the current study did not
make such an analysis.
NO is reported to enhance TGF-1 activity.
21 The role
of NO in apoptosis is controversial, but attenuation of NO
is known to have a key role in the activation of the caspase
cascade. The iNOS upregulation observed here was signif-
icant as well as differentially upregulated in tortuous and
nontortuous areas of the varicose veins. The expression of
iNOS was very intense and implicates the induction of NO
in these cells of the varicose vein tissues that can trigger a
cascade of molecular events remaining to be elucidated.
Both being pleiotropic, their effects are highly cell/tissue-
specific and concentration-dependent. It is possible that
multiple mechanisms are involved that may be partly medi-
ated by TGF-1 induction.
It is noteworthy that an increased presence of CD68
cells, used for detection of monocytes/macrophages, was
observed in both tortuous as well as nontortuous segments
of the varicose vein wall. We had performed a battery of
immunohistochemical assays for identifying the cells in the
tissues of normal and varicose vein tissues. These included
assays for pan T cells (CD3), cytotoxic T cells (CD8), B
cells (CD20), and Ki 1 in T and B cells (CD30). How-
ever, only monocytes/macrophages were present in signif-
icantly high numbers in the diseased tissues compared with
controls. Sayer et al22 also recently reported that varicose
veins display a greater inflammatory cell infiltrate than
normal vein. The monocytes/macrophages increase in
varix tissues correlates with increased TGF-1 and iNOS
expression. CD68 cells were absent or rarely present in
control veins tissues.
Other investigators have reported that monocytes/
macrophages migrate into the venous walls and valves of
patients with venous insufficiency, activating not only lu-
minal venous endothelium but also endothelium in the vasa
vasorum of refluxing saphenous veins.23 The functional
activation of monocyte/macrophages related to venous
stasis as a consequence of venous hypertension has also
been demonstrated.24 Our results are further evidence of
the role of the invading monocytes/macrophages in the
etiology of varicose veins.
We speculate that NO released in the venous tissue by
the upregulation of iNOS enhances the production of
TGF-1 in varicose veins. This correlates with our previous
results of downregulation of mediators of apoptosis. The
endothelial isoform of NOS was expressed in all the samples
studied. However, its expression in the various groups did
not differ significantly. It is likely that the small amounts of
NO produced by eNOS, although having a role in the
regulation of the vascular tone, do not affect the pathogen-
esis of the varix development as much as the large amounts
of NO produced by iNOS.In conclusion, this study has demonstrated for the first
time a correlation between TGF-1, iNOS, and monocyte/
macrophage infiltration and loss of mural integrity in both
tortuous and nontortuous varicose veins. The precise
mechanisms underlying the effects of TGF-1 and iNOS
upregulation and the molecular pathways leading to their
differential expression in the venous wall layers are not clear
at present. We are in the process of culturing cells from
patient samples of varicose and normal veins, and it may be
possible to study the expression and effects of these mole-
cules in vitro to further explore the pathogenesis of primary
venous dysfunction.
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